文献速递脑血管病

房颤相关卒中及病前抗凝治疗的时间趋势:基于人群的研究与系统综述

Time Trends in Atrial Fibrillation-Associated Stroke and Premorbid Anticoagulation: Population-Based Study and Systematic Review.
PubMed 文献 · Stroke · 2018-11-29

该研究基于OXVASC人群队列(2002-2017)及系统综述,发现约1/3的缺血性卒中与房颤相关,且病前抗凝比例虽随时间上升但仍存在显著治疗不足,提示改善抗凝可减轻卒中负担。

要点

  • 约1/3的缺血性卒中与房颤相关,部分归因于已知房颤患者抗凝率低。
  • 病前抗凝比例随时间上升,但近期仍不足(2010年后汇总仅31.6%)。
  • 改善房颤抗凝是减少卒中负担的重要公共卫生机会。

核心结论

  • 约1/3的缺血性卒中仍与房颤相关,部分由于已知房颤患者抗凝率低,这构成了减少卒中负担的重要公共卫生机会。

研究设计与样本

  • 基于OXVASC人群研究(2002-2017)确定 incident 卒中中房颤相关比例,并系统检索截至2017年12月的前瞻性人群卒中发病率研究。
  • 采用Mantel-Haenszel法合并比例,并按研究人群年龄、研究中期年份、国家和种族分层分析。

主要发现

  • OXVASC中1928例缺血性卒中患者,629例(32.6%;95%CI 30.5-34.7)与房颤相关,与同期4项较小研究的合并估计(608/1948;31.2%,30.0-32.4;Phet=0.80)一致。
  • OXVASC中病前抗凝的缺血性卒中比例随时间增加(2002-2007:15.1%,2008-2012:19.6%,2013-2017:35.9%;Ptrend<0.0001),所有研究中也呈增加趋势(P=0.002)。
  • 合并估计显示即使近期时段仍存在显著治疗不足(2001-2015:25.7%,21.1-30.3;≥2010:31.6%,18.2-44.9)。

临床怎么用

  • 临床应重视房颤患者的抗凝治疗以降低卒中风险,尤其应识别并纠正抗凝不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Prevalence of atrial fibrillation (AF) is increasing, but the impact on overall burden of stroke is uncertain, as is the proportion that could be attributed to under anticoagulation. We did a population-based study of AF-associated stroke and a systematic review of time trends in other stroke incidence studies and of rates of premorbid anticoagulation. Methods- The proportion of incident strokes with associated AF was determined in the OXVASC (Oxford Vascular Study; 2002-2017) and in other prospective, population-based stroke incidence studies published before December 2017. Proportions were pooled by Mantel Haenszel methods, and the pooled percentage of cases with premorbid anticoagulation was determined. Analyses were stratified by the age of study population, mid-study year, country, and ethnicity. Results- Of 1928 patients with incident ischemic stroke in OXVASC, 629 (32.6%; 95% CI, 30.5-34.7) were AF associated, consistent with the pooled estimate from 4 smaller studies over the same study period (608/1948; 31.2%, 30.0-32.4; Phet=0.80). The pooled estimate from all studies reporting premorbid AF over 25 million person-years of observation (1960 onwards; 33 reports) was lower (18.6%, 16.8-20.3) and more heterogeneous (Phet<0.0001), but 62% of heterogeneity was explained by the age of study population, study period, country, and ethnicity. The proportion of incident strokes on premorbid anticoagulation increased over time, both for ischemic stroke in OXVASC (2002-2007: 15.1%, 2008-2012: 19.6%, and 2013-2017: 35.9%; Ptrend<0.0001), and across all studies (P=0.002), but the pooled estimates suggested substantial undertreatment even in the most recent periods (2001-2015: 25.7%, 21.1-30.3 and ≥2010: 31.6%, 18.2-44.9). Conclusions- About 1 in 3 incident ischemic strokes are still AF associated, due partly to low rates of anticoagulation for known prior AF, which therefore represents a major public health opportunity to reduce the burden of stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Yiin GSC, Li L, Bejot Y, et al. Time Trends in Atrial Fibrillation-Associated Stroke and Premorbid Anticoagulation: Population-Based Study and Systematic Review. Stroke. 2018. PMID: 30580714. doi:10.1161/STROKEAHA.118.022249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。